Back to FEDERATED HERMES, INC. FEDERATED HERMES, INC.

GWPHGWPH
11 quarters

Position history for FEDERATED HERMES, INC.FEDERATED HERMES, INC.'s holdings in GW PHARMACEUTICALS -ADR

As of its Q1 2021 13F, Federated Hermes held 220,000 shares of GWPH (GW Pharmaceuticals), worth $47.7M. Federated Hermes' 13F filings listed GWPH from Q4 2018 to Q1 2021, 10 quarterly filings. GWPH was 0.1% of Federated Hermes' reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$33M

Total Shares Change

-338,383

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2021-Q1
Decreased
220,000
-69.6%
$47.7M0.1%—
0
2020-Q4
Decreased
723,715
-16.0%
$83.5M0.2%—
0
2020-Q3
Increased
861,744
+4.7%
$83.9M0.2%—
37
2020-Q2
Increased
823,400
+9.3%
$101M0.3%—
39
2020-Q1
Increased
753,432
+132.3%
$66M0.2%—
57
2019-Q4
Increased
324,400
+13.1%
$33.9M0.1%—
33
2019-Q3
Decreased
286,790
-6.0%
$33M0.1%—
0
2019-Q2
Decreased
305,200
-26.9%
$52.6M0.1%—
0
2019-Q1
Increased
417,750
+23.4%
$70.4M0.2%—
43
2018-Q4
First report
338,383
-
$33M0.1%—
0

Other major holders of GWPH: Capital Research Global Investors, Capital World Investors, Pentwater Capital Management LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used